Tolerability of Sacubitril/Valsartan in Patients With Durable Left Ventricular Assist Devices

被引：3
|
作者：
Sharma, Abhinav [1 ,2 ]
Moayedi, Yasbanoo [1 ,3 ]
Duclos, Sebastien [1 ]
Teuteberg, Jeffrey [1 ]
Banerjee, Dipanjan [1 ]
机构：
[1] Stanford Univ, Div Cardiol, Palo Alto, CA 94304 USA
[2] McGill Univ, Ctr Hlth, Div Cardiol, Montreal, PQ, Canada
[3] Univ Toronto, Univ Hlth Network, Ted Rogers Ctr Excellence Heart Funct, Toronto, ON, Canada
来源：
ASAIO JOURNAL | 2020年 / 66卷 / 03期
关键词：
heart failure; LVAD; sacubitril; valsartan; HEART; SUPPORT;
D O I：
10.1097/MAT.0000000000000957
中图分类号：
R318 [生物医学工程];
学科分类号：
0831 ;
摘要：
[No abstract available]
引用
收藏
页码：E44 / E45
页数：2
相关论文
共 50 条
  • [1] Effects of sacubitril/valsartan in patients with left ventricular assist devices: Case series
    Zorz, Neza
    Frljak, Sabina
    Vrtovec, Bojan
    ARTIFICIAL ORGANS, 2021, 45 (02) : 185 - 186
  • [2] Safety and Effectiveness of Sacubitril/Valsartan in Patients with a Left Ventricular Assist Device
    Straw, L. B.
    Bowe, S.
    Sloan, B.
    Reihart, L. G.
    Mardis, C. R.
    McCann, P. J.
    Napier, R. S.
    Mardis, A.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2021, 40 (04): : S445 - S446
  • [3] Successful Use of Sacubitril/Valsartan in Patients with a Left Ventricular Assist Device
    Straw, L. B.
    McCann, P.
    Napier, R.
    Mardis, C.
    Mardis, A.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2020, 39 (04): : S505 - S506
  • [4] Use of sacubitril-valsartan in blood pressure control with left ventricular assist devices
    Dobarro, David
    Diez-Lopez, Carles
    Couto-Mallon, David
    Castrodeza, Javier
    Gomez-Bueno, Manuel
    Tobar, Javier
    McKenzie, Scott
    Goncalves, Antonio
    Melendo-Viu, Maria
    Ortiz, Carlos
    Gonzalez-Costello, Jose
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2020, 39 (12): : 1499 - 1501
  • [5] Neurohormonal Blockade with Sacubitril/Valsartan in Left Ventricular Assist Device (LVAD) Patients
    Njue, F.
    Collins, K.
    Hayes, H.
    Barber, J.
    Lam, K.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2018, 37 (04): : S484 - S484
  • [6] Future Directions for Investigating Sacubitril-Valsartan in Left Ventricular Assist Device Patients
    Goldberg, Rachel L.
    Hsu, Steven
    ASAIO JOURNAL, 2022, 68 (02) : E38 - E38
  • [7] Sacubitril/Valsartan Improves Outcomes in Left Ventricular Assist Device Recipients
    Roberts, S.
    Stoller, D. A.
    Lyden, E.
    Lowes, B.
    Zolty, R.
    Um, J.
    Lundgren, S.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2022, 41 (04): : S352 - S353
  • [8] Pharmacotherapy for durable left ventricular assist devices
    Hollis, Ian B.
    Doligalski, Christina T.
    Jennings, Douglas J.
    PHARMACOTHERAPY, 2021, 41 (01): : 14 - 27
  • [9] Sacubitril-Valsartan versus Standard Anti -Hypertensives in Left Ventricular Assist Device Patients
    Nicolsen, Erika
    Curran, Lisa
    Dixon, Stephanie
    Reece, Molly
    Herbert, Sarah
    Clegg, Amy
    Tillery, Michael
    Bensimhon, Daniel
    McLean, Dalton
    JOURNAL OF CARDIAC FAILURE, 2018, 24 (08) : S30 - S30
  • [10] ANGIOTENSIN II FOR DISTRIBUTIVE SHOCK IN PATIENTS WITH DURABLE LEFT VENTRICULAR ASSIST DEVICES
    Wieruszewski, Patrick
    Seelhammer, Troy
    Khanna, Ashish
    Gaglani, Bhavita
    Davison, Danielle
    Chow, Jonathan
    Busse, Laurence
    Ten Lohuis, Caitlin
    Barreto, Erin
    Wittwer, Erica
    CRITICAL CARE MEDICINE, 2022, 50 (01) : 754 - 754
12345